Alan Cohen 
Member since Aug 1, 2015


Stats

Favorite Places

  • None.
Find places »

Saved Events

  • Nada.
Find events »

Saved Stories

  • Nope.
Find stories »

Custom Lists

  • Zip.

Friends

  • No friends yet.
Become My Friend Find friends »

Recent Comments

Re: “Medical Cannabis Advocates Relieved that Anti-Marijuana Crusader Melinda Haag Is Quitting

The DEA will much more readily increase a drug/medication/ or substance to a more restrictive status. It is an extremely rare event for them to lower it , particularly a C-I controlled drug.
Cannabis used to be on the U.S. Pharmacopeia list as a treatment for epilepsy. There is legitimate research to support its use for several medical conditions. It's side effect profile is more benign than many unscheduled drugs and over-the-counter medications , some of which can even cause loss of life( NSAIDS, as an example).
Cannabis has risks associated with its use. It should be respected as such, not misused, nor taken injudiciously. Allowing legitimate medical use, reducing the restricted status and removing physicians' concerns about federal retaliation against their DEA licensure, would all serve to enhance quality control, research and knowledge about the best clinical indications for prescribing this seriously underutilized treatment option.
Pharmaceutical companies can't get medical use patents, and thus the profit isn't there for them to apply pressure for reducing the Controlled Drug status. Growing certain genetic strains with specific alkaloid concentrations of cannabidiol and THC, amongst others, may encourage private industry funding, as seen in the agricultural field of seed patents.

4 likes, 0 dislikes
Posted by Alan Cohen on 08/01/2015 at 5:41 PM

Readers' Favorites

Most Popular Stories


© 2017 East Bay Express    All Rights Reserved
Powered by Foundation